6/27/2025

Source: SeekingAlpha

6/20/2025

Chemed’s first quarter results saw a negative market response, despite revenue and non-GAAP earnings per share modestly exceeding Wall Street expectations. Management highlighted strong performance at its VITAS hospice subsidiary, driven by higher admissions and average daily census, partially supported by the Covington Health acquisition. CEO Kevin McNamara said, “VITAS continued its strong operating performance,” noting strategic efforts to navigate Medicare cap constraints. Meanwhile, Roto Ro

Source: Yahoo

6/16/2025

The portfolio outperformed its FTSE Global Infrastructure benchmark as well as global equity markets as measured by the MSCI All Country World Index. Read more here.

Source: SeekingAlpha

6/13/2025

Source: SeekingAlpha

6/13/2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Source: Yahoo

6/9/2025

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the senior health, home health & hospice industry, including Chemed (NYSE:CHE) and its peers.

Source: Yahoo

6/6/2025

Chemed has been treading water for the past six months, recording a small return of 1.5% while holding steady at $560.78.

Source: Yahoo

6/4/2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 12.3%. This performance was noticeably worse than the S&P 500’s 1.9% fall.

Source: Yahoo

5/25/2025

Source: SeekingAlpha

5/23/2025

AMED vs. CHE: Which Stock Is the Better Value Option?

Source: Yahoo

5/23/2025

Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Source: Yahoo

5/23/2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how BrightSpring Health Services (NASDAQ:BTSG) and the rest of the senior health, home health & hospice stocks fared in Q1.

Source: Yahoo

5/19/2025

CINCINNATI, May 19, 2025--Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company’s 2025 annual stockholders’ meeting.

Source: Yahoo

5/14/2025

CINCINNATI, May 14, 2025--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Global Healthcare Conference on Wednesday, May 21, 2025, at approximately 9:30 a.m. (ET) at The InterContinental New York Barclay Hotel in New York City.

Source: Yahoo

5/14/2025

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...

Source: Yahoo

5/13/2025

For the three months ended March 31, 2025, the total return on the Ave Maria Rising Dividend Fund was 3.77%.

Source: SeekingAlpha

5/12/2025

Healthcare services company Chemed Corporation (NYSE:CHE) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 9.8% year on year to $646.9 million. Its non-GAAP profit of $5.63 per share was 1.5% above analysts’ consensus estimates.

Source: Yahoo

5/8/2025

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at AdaptHealth (NASDAQ:AHCO) and its peers.

Source: Yahoo

5/6/2025

CINCINNATI, May 06, 2025--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 3:40 PM (PDT) at the Encore at the Wynn Las Vegas.

Source: Yahoo

5/6/2025

Presenter SpeechJoanna Gajuk Thank for joining the Bank of America Securities 2025 Health Care Conference. So thanks so much. So now this session, I'm pleased to present or have a discussion with...

Source: Finnhub